Advertisement
ADUS vs MD
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADUS is a Buy and MD is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ADUS’s FA Score shows that 0 FA rating(s) are green whileMD’s FA Score has 1 green FA rating(s).
- ADUS’s FA Score: 0 green, 5 red.
- MD’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ADUS’s TA Score shows that 5 TA indicator(s) are bullish while MD’s TA Score has 5 bullish TA indicator(s).
- ADUS’s TA Score: 5 bullish, 4 bearish.
- MD’s TA Score: 5 bullish, 4 bearish.
Price Growth
ADUS (@Hospital/Nursing Management) experienced а +5.83% price change this week, while MD (@Hospital/Nursing Management) price change was +2.17% for the same time period.
The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was +2.92%. For the same industry, the average monthly price growth was +109.77%, and the average quarterly price growth was +97.23%.
Reported Earning Dates
ADUS is expected to report earnings on Nov 03, 2025.
MD is expected to report earnings on Oct 30, 2025.
Industries' Descriptions
@Hospital/Nursing Management (+2.92% weekly)Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.
| ADUS | MD | ADUS / MD | |
| Capitalization | 2.11B | 1.44B | 147% |
| EBITDA | 135M | 204M | 66% |
| Gain YTD | -8.520 | 25.610 | -33% |
| P/E Ratio | 25.31 | 12.68 | 200% |
| Revenue | 1.27B | 1.94B | 66% |
| Total Cash | 91.2M | 348M | 26% |
| Total Debt | 222M | 650M | 34% |
ADUS | MD | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 71 | 66 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 72 Overvalued | 56 Fair valued | |
PROFIT vs RISK RATING 1..100 | 74 | 100 | |
SMR RATING 1..100 | 77 | 56 | |
PRICE GROWTH RATING 1..100 | 58 | 45 | |
P/E GROWTH RATING 1..100 | 73 | 24 | |
SEASONALITY SCORE 1..100 | 50 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
MD's Valuation (56) in the Medical Or Nursing Services industry is in the same range as ADUS (72). This means that MD’s stock grew similarly to ADUS’s over the last 12 months.
ADUS's Profit vs Risk Rating (74) in the Medical Or Nursing Services industry is in the same range as MD (100). This means that ADUS’s stock grew similarly to MD’s over the last 12 months.
MD's SMR Rating (56) in the Medical Or Nursing Services industry is in the same range as ADUS (77). This means that MD’s stock grew similarly to ADUS’s over the last 12 months.
MD's Price Growth Rating (45) in the Medical Or Nursing Services industry is in the same range as ADUS (58). This means that MD’s stock grew similarly to ADUS’s over the last 12 months.
MD's P/E Growth Rating (24) in the Medical Or Nursing Services industry is somewhat better than the same rating for ADUS (73). This means that MD’s stock grew somewhat faster than ADUS’s over the last 12 months.
| ADUS | MD | |
|---|---|---|
| RSI ODDS (%) | N/A | 1 day ago 86% |
| Stochastic ODDS (%) | 1 day ago 66% | 1 day ago 71% |
| Momentum ODDS (%) | 1 day ago 70% | 1 day ago 74% |
| MACD ODDS (%) | 1 day ago 59% | 1 day ago 71% |
| TrendWeek ODDS (%) | 1 day ago 68% | 1 day ago 69% |
| TrendMonth ODDS (%) | 1 day ago 64% | 1 day ago 66% |
| Advances ODDS (%) | 1 day ago 66% | 7 days ago 69% |
| Declines ODDS (%) | 8 days ago 64% | 9 days ago 72% |
| BollingerBands ODDS (%) | 1 day ago 73% | 1 day ago 73% |
| Aroon ODDS (%) | 1 day ago 52% | 1 day ago 58% |
Advertisement
ADUS and
Correlation & Price change
A.I.dvisor indicates that over the last year, ADUS has been loosely correlated with BKD. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if ADUS jumps, then BKD could also see price increases.
| Ticker / NAME | Correlation To ADUS | 1D Price Change % | ||
|---|---|---|---|---|
| ADUS | 100% | +0.41% | ||
| BKD - ADUS | 33% Loosely correlated | +0.85% | ||
| CHE - ADUS | 32% Poorly correlated | -0.44% | ||
| PNTG - ADUS | 32% Poorly correlated | -0.33% | ||
| MD - ADUS | 32% Poorly correlated | -0.48% | ||
| DVA - ADUS | 30% Poorly correlated | +1.28% | ||
More | ||||
MD and
Correlation & Price change
A.I.dvisor indicates that over the last year, MD has been loosely correlated with SEM. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if MD jumps, then SEM could also see price increases.